NCT02781272 2023-06-05
EMBER
Angle plc
Completed
Clinical Trials
5 trialsNCT03355820 2020-11-19
A Follow-up Extension Study to Evaluate the Persistence of Immune Response to GSK Biologicals' HPV Vaccine in Healthy Chinese Female Subjects Who Received Three Doses of the Vaccine in the HPV-058 Study
GlaxoSmithKline
Phase 3 Completed
NCT00947115 2020-10-30
Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects
GlaxoSmithKline
Phase 3 Completed
NCT02016833 2015-04-30
Development of Immunological Assays for the Evaluation of Tumor Antigen Specific Immunity
PX Biosolutions
Completed
NCT00436189 2008-04-30
Assess Cancer in Ovarian Tumors With Biomarkers.
Ciphergen Biosystems
Phase NA Completed